Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Schaefer

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
Der Urologe. Ausg. A|September 10, 2015
[The dilemma with PREFERE (and other studies)]R M Schaefer
Krankenpflege Journal|July 1, 1988
[Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin]R M Schaefer
Clinical Nephrology|April 4, 2000
Iron metabolism in rhEPO-treated hemodialysis patientsR M Schaefer, U Bahner
Contributions to Nephrology|January 1, 1984
Captopril--indications and clinical problemsR M Schaefer, A Heidland
Deutsche Medizinische Wochenschrift (1946)|June 30, 1989
[Erythropoietin, blood viscosity and hypertension in chronic kidney failure]R M Schaefer, A Heidland
Advances in Experimental Medicine and Biology|January 1, 1989
Pathophysiology and treatment of hypertension in dialysis patientsA Heidland, R M Schaefer
EDTNA/ERCA Journal (English Ed.)|March 18, 2003
Iron management in renal failure patients--how do we achieve the best results?M Kosch, R M Schaefer
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 1, 1997
Heterozygosity for factor V Leiden in a haemodialysis patient with recurrent shunt thrombosisC Bremer, R M Schaefer
Kidney International. Supplement|March 20, 1999
Hypochromic red blood cells and reticulocytesR M Schaefer, L Schaefer
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 5, 1998
Iron monitoring and supplementation: how do we achieve the best results?R M Schaefer, L Schaefer
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
Der Urologe. Ausg. A|September 10, 2015
[The dilemma with PREFERE (and other studies)]R M Schaefer
Krankenpflege Journal|July 1, 1988
[Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin]R M Schaefer
Clinical Nephrology|April 4, 2000
Iron metabolism in rhEPO-treated hemodialysis patientsR M Schaefer, U Bahner
Contributions to Nephrology|January 1, 1984
Captopril--indications and clinical problemsR M Schaefer, A Heidland
Deutsche Medizinische Wochenschrift (1946)|June 30, 1989
[Erythropoietin, blood viscosity and hypertension in chronic kidney failure]R M Schaefer, A Heidland
Advances in Experimental Medicine and Biology|January 1, 1989
Pathophysiology and treatment of hypertension in dialysis patientsA Heidland, R M Schaefer
EDTNA/ERCA Journal (English Ed.)|March 18, 2003
Iron management in renal failure patients--how do we achieve the best results?M Kosch, R M Schaefer
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 1, 1997
Heterozygosity for factor V Leiden in a haemodialysis patient with recurrent shunt thrombosisC Bremer, R M Schaefer
Kidney International. Supplement|March 20, 1999
Hypochromic red blood cells and reticulocytesR M Schaefer, L Schaefer
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 5, 1998
Iron monitoring and supplementation: how do we achieve the best results?R M Schaefer, L Schaefer
Pageof 17